Log in to save to my catalogue

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receivin...

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receivin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b886bdc66c744576bec9567dfc8ec7ee

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421)

About this item

Full title

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421)

Publisher

Cham: Springer International Publishing

Journal title

Journal of Patient-Reported Outcomes, 2018-06, Vol.2 (1), p.27-27, Article 27

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background
SWOG S0421 was a large randomized trial comparing docetaxel/prednisone plus placebo (DPP) to docetaxel/prednisone plus atrasentan over 12 cycles for patients with metastatic castration-resistant prostate cancer (mCRPC). The current report presents the PRO results for this trial, an important secondary endpoint.
Methods
The trial...

Alternative Titles

Full title

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b886bdc66c744576bec9567dfc8ec7ee

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b886bdc66c744576bec9567dfc8ec7ee

Other Identifiers

ISSN

2509-8020

E-ISSN

2509-8020

DOI

10.1186/s41687-018-0054-5

How to access this item